Td Waterhouse Canada Inc. Altimmune, Inc. Transaction History
Td Waterhouse Canada Inc.
- $15.3 Trillion
- Q3 2025
A detailed history of Td Waterhouse Canada Inc. transactions in Altimmune, Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 3,500 shares of ALT stock, worth $14,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,500
Previous 3,500
-0.0%
Holding current value
$14,245
Previous $14.7 Million
8.1%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
213Shares Held
35.1MCall Options Held
4.92MPut Options Held
4.18M-
Black Rock Inc. New York, NY5.32MShares$21.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$21 Million0.0% of portfolio
-
State Street Corp Boston, MA2.75MShares$11.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$11.2 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA1.93MShares$7.87 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $200M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...